Merck Ventures backs Macrophage Pharma
Macrophage Pharma Limited, an immuno-oncology research and development company, has secured an undisclosed amount of funding from Merck Ventures to complete its Series A round. In addition to the funding, Hakan Goker, senior investment director at Merck Ventures, has been appointed to Macrophage Pharma's board of directors.
23 August 2017•1 min read
